WHO ICTRP trial
Different administration of Endostar Combined with Paclitaxel and Carboplatin in…
ChiCTR1800015862 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800015862 |
|---|---|
| Public title | Different administration of Endostar Combined with Paclitaxel and Carboplatin in the Treatment of Advanced Non Small Cell Lung Cancer |
| Scientific title | Different administration of Endostar Combined with Paclitaxel and Carboplatin in the Treatment of Advanced Non Small Cell Lung Cancer |
| Primary sponsor | Fujian Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | China |
| Conditions | Advanced Non Small Cell Lung Cancer |
| Interventions | Pumping group:endostar continuous intravenous infusion by pumping;Normal infusion group:endostar normal infusion group |
| Registration date | Apr 25, 2018 |
| Target size | Pumping group:30;Normal infusion group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: